High-throughput Single Cell Co-assay of Histone Modifications and Transcriptome

NIH RePORTER · NIH · R41 · $350,000 · view on reporter.nih.gov ↗

Abstract

Abstract Epigenome analysis can help dissect the transcriptional regulatory sequences that control spatiotemporal patterns of gene expression during anima development and disease pathogenesis, but a major challenge to epigenome analysis is the heterogeneity of primary tissues. Conventional epigenome assays that take bulk tissues as input only produce population average signals. To address this major bottleneck, we propose to develop an ultra-high throughput single-cell multi-omics method, Paired-Tag, for joint profiling of histone modifications and transcriptome. In preliminary experiments, we have demonstrated the feasibility and utility of this method through analysis of the nuclear transcriptome and multiple histone modifications at single cell resolution in the adult mouse frontal cortex and hippocampus. In the proposed study, we will further optimize the current Paired-Tag protocol and demonstrate its utility in cancer epigenome analysis. If successful, the research would add a major toolkit for the production of cell-type-resolved maps of chromatin state and transcriptome in complex tissues and enable next generation epigenome analysis of tumor samples.

Key facts

NIH application ID
10324108
Project number
1R41GM146330-01
Recipient
EPIGENOME TECHNOLOGIES, INC.
Principal Investigator
Bing Ren
Activity code
R41
Funding institute
NIH
Fiscal year
2021
Award amount
$350,000
Award type
1
Project period
2021-09-15 → 2022-08-31